Impax Asset Management Group plc Raises Holdings in Agilent Technologies, Inc. (NYSE:A)

Impax Asset Management Group plc lifted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 8.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 2,667,616 shares of the medical research company’s stock after buying an additional 203,234 shares during the period. Agilent Technologies accounts for approximately 1.6% of Impax Asset Management Group plc’s portfolio, making the stock its 19th largest holding. Impax Asset Management Group plc owned approximately 0.93% of Agilent Technologies worth $396,088,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the business. Crewe Advisors LLC boosted its stake in Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 101 shares during the last quarter. Livelsberger Financial Advisory acquired a new position in shares of Agilent Technologies during the third quarter valued at $28,000. Ridgewood Investments LLC bought a new stake in shares of Agilent Technologies in the 2nd quarter worth $29,000. Fortitude Family Office LLC raised its holdings in shares of Agilent Technologies by 68.3% in the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after purchasing an additional 95 shares in the last quarter. Finally, Ashton Thomas Private Wealth LLC purchased a new position in Agilent Technologies in the 2nd quarter worth about $39,000.

Insider Buying and Selling

In other news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the sale, the chief executive officer now directly owns 24,118 shares in the company, valued at $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 11,995 shares of company stock worth $1,739,510.

Analyst Upgrades and Downgrades

A has been the subject of several analyst reports. Wells Fargo & Company initiated coverage on shares of Agilent Technologies in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price objective for the company. Stifel Nicolaus reaffirmed a “buy” rating and issued a $151.00 price target on shares of Agilent Technologies in a research report on Monday, August 26th. TD Cowen increased their price objective on Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Evercore ISI boosted their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Finally, Barclays increased their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a report on Tuesday, October 15th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and an average price target of $144.36.

Agilent Technologies Trading Up 1.4 %

Shares of NYSE:A traded up $1.94 during mid-day trading on Monday, reaching $138.81. The stock had a trading volume of 495,763 shares, compared to its average volume of 1,676,897. The firm has a market cap of $39.88 billion, a PE ratio of 28.40, a price-to-earnings-growth ratio of 6.26 and a beta of 1.07. The firm has a 50 day simple moving average of $139.73 and a two-hundred day simple moving average of $138.08. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a twelve month low of $104.09 and a twelve month high of $155.35.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the previous year, the company posted $1.43 earnings per share. The company’s revenue for the quarter was down 5.6% on a year-over-year basis. On average, research analysts predict that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were given a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date was Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is presently 19.50%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.